Champions Oncology Inc expected to post a loss of 1 cent a share - Earnings Preview

Champions Oncology

07/03/2025 20:08

Champions Oncology Inc CSBR.OQ CSBR.O is expected to show a rise in quarterly revenue when it reports  results on March 11 for the period ending January 31 2025

The Hackensack New Jersey-based  company is expected to report a 7.6% increase in revenue to $12.932 million from $12.02 million a year ago, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for Champions Oncology Inc is for a loss of 1 cent per share.

The one available analyst rating on the shares is "buy".

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Champions Oncology Inc is $8.00​, below​ its last closing price of $10.01. ​​​

This summary was machine generated March 7 at 20:08 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)